Results 91 to 100 of about 4,435,862 (297)
, 2018 Majed S Al Yami,1,2 Sawsan Kurdi,2,3 Ivo Abraham2,4,5 1Department of Pharmacy Practice, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 2Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson,
Al Yami MS, Abraham I, Kurdi S
core
British Journal of Clinical Pharmacology, EarlyView.Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou +10 more
wiley +1 more source
Реальная клиническая практика: данные и доказательстваThis article presents the results of a safety study of oral anticoagulants in surgical patients with polypharmacy. An analysis of medical records of inpatients receiving oral anticoagulants for the prevention of venous thromboembolic complications was ...
E. R. Kadyseva, V. N. Khaziakhmetova
doaj +1 more source
Harnessing blood clot as a native scaffold for orchestrating tissue repairs and regeneration
BMEMat, EarlyView.The blood clot, owing to its dynamic composition and unique microenvironment, holds significant yet underappreciated potential for tissue engineering. This review systematically summarizes the pathophysiology of clot formation, the key regulatory factors shaping its microenvironment, and its applications in both pre‐clinical and clinical settings ...
Gao‐peng Dang +13 more
wiley +1 more source
New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery.
Medicina oral, patologia oral y cirugia bucal, 2017 Thrombotic disorders remain a leading cause of death in the Western World. For decades, vitamin K antagonists used in the prevention of this pathology, such as warfarin or sintrom, were the only oral agents available for long-term anticoagulation, in spite of their disadvantages.An electronic database search was carried out on MedLine and The Cochrane ...
Serrano-Sánchez,Víctor +7 more
openaire +3 more sources
Evaluation of bleeding in patients receiving direct oral anticoagulants
, 2017 Erika L Hellenbart,1 Kathleen D Faulkenberg,2 Shannon W Finks3 1University of Illinois at Chicago College of Pharmacy, Chicago, IL, 2Cleveland Clinic, Cleveland, OH, 3University of Tennessee College of Pharmacy, Memphis, TN, USA Abstract: Direct oral ...
Faulkenberg KD, Hellenbart EL, Finks SW
core
Clinical Advances in Periodontics, EarlyView.Abstract Background Medication‐related osteonecrosis of the jaw (MRONJ) is a challenging complication associated with antiresorptive medications. Its exact pathophysiology remains unclear, but dental extractions and infections are known triggers, complicating prevention, and treatment.
Pedro Franco Ferreira +3 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Calcified nodules (CN) and nodular calcifications (NC) present significant challenges during percutaneous coronary intervention (PCI) because of their protruding morphology and high rigidity, which often result in inadequate stent expansion and suboptimal procedural outcomes.
Akito Setoguchi +7 more
wiley +1 more source
Direct oral anticoagulants in cirrhosis: Rationale and current evidence. [PDF]
Cirrhosis is a major health concern worldwide with a complex pathophysiology affecting various biological systems, including all aspects of haemostasis.
Bertaggia Calderara, Debora +21 more
core +2 more sources
Open Heart, 2019 Purpose We sought to assess the safety of performing diagnostic radial access coronary angiography with uninterrupted anticoagulation on patients receiving direct oral anticoagulant therapy.Background Direct oral anticoagulants have become a popular ...
Napohn Chongprasertpon +6 more
doaj +1 more source